본문으로 바로가기

의료진 소개

성연아 의사

성연아 교수


내분비내과 관심의료진 등록

전문 진료 분야

당뇨병, 뇌하수체, 부신질환, 월경이상(다낭난소증후군), 갑상선질환 ※단기연수 (24.10/1~24.11/30)

진료 일정

학력 및 경력사항

학력사항

  • 이화여자대대학교 의과대학 대학원 박사
  • 이화여자대대학교 의과대학 대학원 석사
  • 이화여자 대학교 의과대학 의학과 졸업

교육 및 연구경력

  • 2015-현재  | 이화의대 목동병원 내분비내과 분과장
  • 2013-2015  | 이화여자대학교 의과대학 부속 목동병원 당뇨센터장
  • 2013-현재  | 이대목동병원 내과 과장
  • 2004  | 이화여자대학교 의과대학 내과학교실 교수
  • 2003-2004  | 미국 Northwestern대학 내분비내과 visiting scholar
  • 1993-2004  | 이화여자대학교 의과대학 내과학교실 전임강사, 조교수, 부교수
  • 1992-1993  | 미국 University of Wisconsin 내분비내과 fellow
  • 1991-1992  | 서울대학교병원전임의
  • 1989-1991  | 이화의대 동대문병원 전임의
  • 1986-1989  | 이화의대 동대문병원 내과전공의

기타 학술 관련 경력

  • 2012-2014  | 대한내분비학회 이사, 홍보위원장
  • 2006-2009  | 대한당뇨병학회 이사, 진단소위원회 위원장
  • 2006  | 대한당뇨병학회 이사, 진단소위원회 위원장

논문

  •  The effect of menopause on cardiovascular risk factors according to body mass index in middle-aged Korean women.  PLoS ONE. 2023, v.18 no.3 (March), e0283393. 
  •  Association of serum creatinine levels and risk of type 2 diabetes mellitus in Korea: a case control study.  BMC Endocrine Disorders. 2022, v.22 no.1, 4. 
  •  Body mass index and stroke risk among patients with diabetes mellitus in Korea.  PLOS ONE. 2022, v.17 no.9, e0275393. 
  •  Waist circumference and mortality or cardiovascular events in a general Korean population.  PLoS ONE. 2022, v.17 no.4-4월, e0267597. 
  •  Association of Vitamin D Deficiency with Diabetic Nephropathy.  ENDOCRINOLOGY AND METABOLISM. 2021, v.36 no.1, 106-113. 
  •  The Association of Ovarian Reserve with Exposure to Bisphenol A and Phthalate in Reproductive-aged Women.  Journal of Korean Medical Science. 2021 , 1-9. 
  •  Relationship between the characteristic traits of polycystic ovary syndrome and susceptibility genes.  Scientific Reports. 2020, v.10 no.1, 10479. 
  •  Insulin resistance is associated with hirsutism in unselected reproductive-aged women.  Clinical Endocrinology. 2019, v.90 no.4, 586-591. 
  •  Vitamin D receptor and binding protein polymorphisms in women with polycystic ovary syndrome: A case control study.  BMC Endocrine Disorders. 2019, v.19 no.1, 145. 
  •  Association between cadmium and anti-Mullerian hormone in premenopausal women at particular ages .  Annals of Occupational and Environmental Medicine. 2018, v.30 no.1, 44. 
  •  Malignancy Risk and Related Factors of Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance in Thyroid Fine Needle Aspiration.  INTERNATIONAL JOURNAL OF ENDOCRINOLOGY. 2018 , 4521984. 
  •  Associations between body mass index and mortality or cardiovascular events in a general Korean population .  PLOS ONE. 2017, v.12 no.9, e0185024. 
  •  Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-Mullerian hormone cutoff value.  KOREAN JOURNAL OF INTERNAL MEDICINE. 2017, v.32 no.4, 690-698. 
  •  Insulin resistance according to beta-cell function in women with polycystic ovary syndrome and normal glucose tolerance.  PLOS ONE. 2017, v.12 no.5. 
  •  Meta-analysis of genome-wide SNP- and pathway-based associations for facets of neuroticism.  JOURNAL OF HUMAN GENETICS. 2017, v.62 no.10, 903-909. 
  •  Polycystic ovary morphology is associated with insulin resistance in women with polycystic ovary syndrome .  CLINICAL ENDOCRINOLOGY. 2017, v.87 no.4, 375-380. 
  •  Urinary bisphenol A is associated with insulin resistance and obesity in reproductive-aged women.  CLINICAL ENDOCRINOLOGY. 2017, v.86 no.4, 506-512. 
  •  A genetic risk score is associated with polycystic ovary syndrome-related traits.  Human Reproduction. 2016, v.31 no.1, 209-215. 
  •  The Role of Serum MicroRNA-6767-5pas a Biomarker for the Diagnosis of Polycystic Ovary Syndrome.  PLOS ONE. 2016, v.11 no.9. 
  •  Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.  Yonsei Medical Journal. 2016, v.57 no.6, 1404~1411. 
  •  A prospective, randomized, multicenter trial comparing the efficacy and safety of the concurrent use of long-acting insulin with mitiglinide or voglibose in patients with type 2 diabetes.  Endocrine Journal. 2015, v.62 no.12, 1049-1057. 
  •   randomized, double-blind, placebo-controlled, phase II clinical trial to investigate the efficacy and safety of oral DA-1229 in patients with type 2 diabetes mellitus who have inadequate glycaemic control with diet and exercise.  Diabetes/Metabolism Research and Reviews. 2015, v.31 no.3. 
  •  A randomized, placebo-controlled, double-blind, phase 3 trial to evaluate the efficacy and safety of anagliptin in drug-naive patients with type 2 diabetes.  ENDOCRINE JOURNAL. 2015, v.62 no.5, 449-462. 
  •  Comparison of the efficacy and safety of once-daily dosing and on-demand use of udenafil for type 2 diabetic patients with erectile dysfunction.  Asian Journal of Andrology. 2015, v.17 no.1, 143-148. 
  •  GWA meta-analysis of personality in Korean cohorts.  Journal of Human Genetics. 2015, v.60 no.8, 455-460. 
  •  Genome-wide association study identified new susceptibility loci for polycystic ovary syndrome.  HUMAN REPRODUCTION. 2015, v.30 no.3, 723-731. 
  •  Increased epicardial adipose tissue thickness in type 2 diabetes mellitus and Obesity.  Diabetes and Metabolism Journal. 2015, v.39 no.5, 405-413. 
  •  Insulin initiation in insulin-naïve korean type 2 diabetic patients inadequately controlled on oral antidiabetic drugs in real-world practice: The modality of insulin treatment evaluation study.  iabetes and Metabolism Journal. 2015, v.39 no.6, 481-488. 
  •  Lobeglitazone and pioglitazone as add-ons to metformin for patients with type 2 diabetes: a 24-week, multicentre, randomized, double-blind, parallel-group, active-controlled, phase III clinical trial with a 28-week extension.  DIABETES OBESITY & METABOLISM. 2015, v.17 no.6, 599-602. 
  •  Pathway Analysis Based on a Genome-Wide Association Study of Polycystic Ovary Syndrome.  PLOS ONE. 2015, v.10 no.8. 
  •  Pathway analysis of genome-wide association datasets of personality traits.  GENES BRAIN AND BEHAVIOR. 2015, v.14 no.4, 345-356. 
  •  A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, PHASE 3 TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF ANAGLIPTIN IN PATIENTS WITH TYPE 2 DIABETES.  DIABETES RESEARCH AND CLINICAL PRACTICE. 2014, v.106, S149-S150. 
  •  Association between Blood Lipid Levels and Personality Traits in Young Korean Women.  PLOS ONE. 2014, v.9 no.9. 
  •  Association between extraversion personality and abnormal glucose regulation in young Korean women.  ACTA DIABETOLOGICA. 2014, v.51 no.3, 421-427. 
  •  Clinical implications of menstrual cycle length in oligomenorrhoeic young women.  CLINICAL ENDOCRINOLOGY. 2014, v.80 no.1, 115-121. 
  •  Comparison of the body adiposity index to body mass index in Korean women.  Yonsei Medical Journal. 2014, v.55 no.4, 1028-1035. 
  •  Duration of diabetes and effectiveness of insulin in the management of insulin-naïve Korean patients uncontrolled on oral antidiabetic drugs: a sub-analysis of the MOdaliTy of Insulin treatment eValuation (MOTIV) registry results.  Acta Diabetologica. 2014, v.51 no.4, 1-7. 
  •  Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome.  HUMAN REPRODUCTION. 2014, v.29 no.12, 2764-2772. 
  •  FTO gene variants are associated with PCOS susceptibility and hyperandrogenemia in young Korean women.  Diabetes and Metabolism Journal. 2014, v.38 no.4, 302-310. 
  •  Hyperandrogenemia is implicated in both the metabolic and reproductive morbidities of polycystic ovary syndrome.  FERTILITY AND STERILITY. 2014, v.101 no.3, 840-845. 
  •  INSULIN RESISTANCE ACCORDING TO beta-CELL FUNCTION IN POLYCYSTIC OVARY SYNDROME WOMEN WITH NORMAL GLUCOSE TOLERANCE.  DIABETES RESEARCH AND CLINICAL PRACTICE. 2014, v.106, S45-S45. 
  •  Pathway Analysis of Metabolic Syndrome Using a Genome-Wide Association Study of Korea Associated Resource (KARE) Cohorts.  Genomics & Informatics. 2014, 제12권 4호, 195-202. 
  •  Personality Traits and Body Mass Index in a Korean Population.  PLOS ONE. 2014, v.9 no.3, Article ID e90516.